Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleOriginal Article

The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere)

Haiyan Lu, Janice Murtagh and Edward L. Schwartz
Molecular Pharmacology April 2006, 69 (4) 1207-1215; DOI: https://doi.org/10.1124/mol.105.019075
Haiyan Lu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice Murtagh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward L. Schwartz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 69 no. 4 1207-1215
DOI 
https://doi.org/10.1124/mol.105.019075
PubMed 
16415178

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received September 21, 2005
  • Accepted January 13, 2006
  • Published online March 21, 2006.

Article Versions

  • Earlier version (January 13, 2006 - 13:06).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Haiyan Lu,
  2. Janice Murtagh and
  3. Edward L. Schwartz
  1. Department of Oncology, Albert Einstein College of Medicine, Bronx, New York
  1. Address correspondence to:
    Edward L. Schwartz, Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467. E-mail: eschwart{at}aecom.yu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2006 to May 2022

AbstractFullPdf
Jan 2006160156
Feb 2006200181
Mar 20064321157
Apr 2006383745
May 2006293325
Jun 2006172517
Jul 2006202832
Aug 2006102832
Sep 2006111519
Oct 2006181519
Nov 2006251320
Dec 2006121018
Jan 2007172223
Feb 2007171315
Mar 2007191622
Apr 2007182333
May 2007113527
Jun 2007132217
Jul 200772030
Aug 2007162233
Sep 200782719
Oct 2007182724
Nov 2007143021
Dec 20071089
Jan 2008162430
Feb 2008291418
Mar 2008301322
Apr 2008282629
May 2008131917
Jun 200891513
Jul 2008241816
Aug 2008533311
Sep 2008743321
Oct 2008312422
Nov 200827217
Dec 200841310
Jan 200919107
Feb 200918125
Mar 2009251610
Apr 2009111013
May 2009111711
Jun 2009111414
Jul 200915145
Aug 2009191223
Sep 20091288
Oct 200929615
Nov 20093559
Dec 20092517
Jan 2010371922
Feb 2010221610
Mar 20107106
Apr 201011217
May 2010231710
Jun 201032114
Jul 201016710
Aug 201022169
Sep 201018910
Oct 20107277
Nov 20108193
Dec 201011137
Jan 2011899
Feb 20118179
Mar 20116218
Apr 2011101111
May 2011131618
Jun 2011785
Jul 201151315
Aug 201171816
Sep 201192612
Oct 2011141210
Nov 2011122910
Dec 201111137
Jan 201210109
Feb 2012142213
Mar 201216812
Apr 2012111814
May 2012111919
Jun 20127128
Jul 2012151614
Aug 20129109
Sep 20129126
Oct 201291110
Nov 201262011
Dec 201211128
Jan 201310126
Feb 201313198
Mar 2013101111
Apr 2013101513
May 201313710
Jun 20138107
Jul 2013875
Aug 2013314
Sep 20131163
Oct 2013766
Nov 20131147
Dec 20131154
Jan 20146104
Feb 2014795
Mar 2014554
Apr 2014101214
May 2014766
Jun 20141083
Jul 2014383
Aug 2014699
Sep 20144125
Oct 2014964
Nov 201491511
Dec 2014553
Jan 2015952
Feb 20151063
Mar 201516166
Apr 2015861
May 20151425
Jun 2015884
Jul 201515128
Aug 201514109
Sep 201515153
Oct 2015482
Nov 2015636
Dec 2015633
Jan 20161356
Feb 201623127
Mar 20161177
Apr 20161377
May 20161434
Jun 20161584
Jul 20161173
Aug 201613149
Sep 20162102
Oct 20164108
Nov 2016679
Dec 20162114
Jan 20170193
Feb 20170100
Mar 20171163
Apr 20171124
May 20170193
Jun 20170253
Jul 20170105
Aug 20171132
Sep 2017094
Oct 20170225
Nov 20171102
Dec 20170151
Jan 20180113
Feb 20183111
Mar 201823013
Apr 20181203
May 20181206
Jun 2018171
Jul 2018184
Aug 20180117
Sep 20180122
Oct 2018084
Nov 20183107
Dec 20181053
Jan 20191407
Feb 20191311
Mar 2019833
Apr 20191413
May 20191311
Jun 20191314
Jul 20191611
Aug 20191500
Sep 20192010
Oct 20191400
Nov 20192710
Dec 20191713
Jan 20201010
Feb 20201021
Mar 20201200
Apr 2020700
May 2020120
Jun 20202432
Jul 20201210
Aug 20201715
Sep 2020523
Oct 20201811
Nov 2020512
Dec 20201511
Jan 20211134
Feb 20211111
Mar 20212223
Apr 20211110
May 20211622
Jun 2021815
Jul 20211615
Aug 2021211
Sep 20211421
Oct 20211832
Nov 20211112
Dec 20212011
Jan 20222611
Feb 20221721
Mar 2022210
Apr 20221211
May 20221303

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 69 (4)
Molecular Pharmacology
Vol. 69, Issue 4
1 Apr 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere)
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleOriginal Article

The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere)

Haiyan Lu, Janice Murtagh and Edward L. Schwartz
Molecular Pharmacology April 1, 2006, 69 (4) 1207-1215; DOI: https://doi.org/10.1124/mol.105.019075

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleOriginal Article

The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere)

Haiyan Lu, Janice Murtagh and Edward L. Schwartz
Molecular Pharmacology April 1, 2006, 69 (4) 1207-1215; DOI: https://doi.org/10.1124/mol.105.019075
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The 73-kDa Heat Shock Cognate Protein Is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-Mediated Chemotaxis
  • Endogenous Regulator of G-Protein Signaling Proteins Regulate the Kinetics of Gαq/11-Mediated Modulation of Ion Channels in Central Nervous System Neurons
  • A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling
Show more ORIGINAL ARTICLE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics